WSI Co Ltd
KOSDAQ:299170
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biohit Oyj
OMXH:BIOBV
|
FI |
WSI Co Ltd
Total Current Liabilities
WSI Co Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
W
|
WSI Co Ltd
KOSDAQ:299170
|
Total Current Liabilities
₩33.8B
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Chorokbaem Healthcare Co Ltd
KRX:118000
|
Total Current Liabilities
₩11.9B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
1%
|
|
|
W
|
Wonik Co Ltd
KOSDAQ:032940
|
Total Current Liabilities
₩48.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-3%
|
|
|
H
|
HLB Life Science Co Ltd
KOSDAQ:067630
|
Total Current Liabilities
₩108.9B
|
CAGR 3-Years
39%
|
CAGR 5-Years
40%
|
CAGR 10-Years
19%
|
|
|
B
|
BlueMTec Co Ltd
KOSDAQ:439580
|
Total Current Liabilities
₩56B
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
WSI Co Ltd
Glance View
WSI Co., Ltd. manufactures medical devices and pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-09-21. The firm mainly distributes the topical hemostatic agent Flosils. In addition, the Company supplies endoscopes related to spinal surgery, anti-adhesion agents, and bone hemostatic agents.
See Also
What is WSI Co Ltd's Total Current Liabilities?
Total Current Liabilities
33.8B
KRW
Based on the financial report for Dec 31, 2024, WSI Co Ltd's Total Current Liabilities amounts to 33.8B KRW.
What is WSI Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 3Y
23%
Over the last year, the Total Current Liabilities growth was 102%. The average annual Total Current Liabilities growth rates for WSI Co Ltd have been 23% over the past three years .
